
EMFGF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for EMFGF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for EMFGF and 80,000+ other tickers.
See exactly how EMFGF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for EMFGF and 80,000+ other tickers.
Fluence Corporation Limited specializes in delivering comprehensive water and wastewater treatment and reuse solutions for municipal, commercial, and industrial clients worldwide. The company's product offerings include cutting-edge desalination technologies like NIROBOX, which purifies seawater, brackish water, fresh water, and wastewater. They also provide the NIROFLEX series, featuring advanced desalination, ultrafiltration, multimedia filtration, and reverse osmosis systems. For wastewater management, Fluence supplies various products such as Aspiral, an innovative treatment solution…

Fluence Corporation Limited (EMFGF) Q2 2026 Earnings Call Transcript

Fluence Corporation Limited (EMFGF) Shareholder/Analyst Call Transcript

Fluence Corporation Limited (EMFGF) Q1 2026 Earnings Call Transcript

Fluence Corporation Limited (EMFGF) Q4 2025 Earnings Call Transcript

Fluence Corporation Limited (OTCPK:EMFGF) Q3 2025 Earnings Call October 29, 2025 6:30 PM EDT Company Participants Andrew Angus Thomas Pokorsky - CEO & MD Benjamin Fash - Chief Financial Officer Presentation Andrew Angus All right. Good morning, and welcome to the Fluence Corporation 3Q 2025 Results Webcast.